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A 78-year-old man was referred for refractory heart failure. He presented in NYHA class IV
with bilateral pleural effusion and peripheral oedema. He was on angiotensin-converting
enzyme inhibitors, furosemide, and aldosterone blockade; beta-blockers were withdrawn
at the time of decompensated heart failure. His blood pressure was 100/70mmHg and
his heart rate was 89 beats/min in sinus rhythm. The 12-lead electrocardiogram showed
microvoltage and negative T waves in V2 to V5. Transthoracic echocardiography revealed
a severely hypokinetic, non-dilated, non-hypertrophied left ventricle (end-diastolic diam-
eter 56mm, wall thickness 11mm, and ejection fraction 25% according to the biplane
Simpson method), two enlarged atria, a restrictive ﬁlling pattern on Doppler transmitral
inﬂow (E/A < 1), 70-mmHg systolic pulmonary arterial pressure, and enlarged inferior vena
cava and sushepatic veins.
The patient underwent cardiovascular magnetic resonance (CMR) (1.5 T Siemens
Symphony®, Erlangen, Germany) for etiological and prognostic purposes. Cine-
CMR conﬁrmed the echocardiographic data (panels A and B in the Fig. 1, andInsufﬁsance
cardiaque ;
Amylose ;
Cardiomyopathie
supplemental movie ﬁle). Dynamic ﬁrst-pass perfusion CMR showed delayed homoge-
neous myocardial ﬁrst-pass perfusion. Ten minutes after gadolinium injection (0.1mm
Dotarem®, Guerbet, Aulnay, France) selection of the inversion time on a dedicated
multiphase sequence (TI scouting, Look Locker) was very difﬁcult because of dif-
fuse circumferential subendocardial enhancement and a small amount of preserved
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Figure 1. Still frames extracted from cine CMR (steady state free precession) in the four-chamber view at (A) end-systole and (B)
end-diastole, conﬁrming the echocardiographic data (non-dilated, non-hypertrophied left ventricle, 25% ejection fraction, dilated atria,
pleural effusion, moderate tricuspid, and mitral regurgitations). Late-enhanced inversion-recovery CMR images show left-ventricular diffuse
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ubepicardial rim (supplemental movie ﬁle). Late contrast-
nhanced CMR showed diffuse circumferential suben-
ocardial enhancement with a preserved subepicardial
im (panels C—F in the Fig. 1), highly suggestive
f cardiac amyloidosis. Amyloid proteins are known
o accumulate preferentially in the subendocardium
ith respect to the subepicardium. The diagnosis of
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ur-chamber view. Note that the right ventricle is most likely to be
ardiac amyloidosis was conﬁrmed on laboratory test-
ng and biopsy. The patient’s clinical outcome wasThis case highlights the incremental value of CMR over
chocardiography for the diagnosis of cardiac amyloidosis in
atients with heart failure. The patterns of late enhance-
ent are very speciﬁc for the disease. CMR should be
AValue of CMR in heart failure
performed in patients for whom the diagnosis is still uncer-
tain after conventional work-up.Conﬂict of interest
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